Evidence map›Paper›PMID 34497683›Full record

ReviewOxidative medicine and cellular longevity2021

The Antiviral Roles of Hydrogen Sulfide by Blocking the Interaction between SARS-CoV-2 and Its Potential Cell Surface Receptors.

Jing Dai, Xu Teng, Sheng Jin, Yuming Wu

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Synthesis, HScientific reports · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Review
  7. Article
  8. Article
  9. Utility of NO and HNitric oxide : biology and chemistry · 2022
    Review
  10. Review
  11. Article
  12. The Effects of HBiomedicines · 2022
    Article
  13. A Whiff of Sulfur: One Wind a Day Keeps the Doctor Away.Antioxidants (Basel, Switzerland) · 2022
    Review
  14. Gases in Sepsis: Novel Mediators and Therapeutic Targets.International journal of molecular sciences · 2022
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jing DaiDepartment of Clinical Diagnostics, Hebei Medical University, Hebei 050017, China.ORCID https://orcid.org/0000-0001-5310-6042
Xu TengDepartment of Physiology, Hebei Medical University, Hebei 050017, China.ORCID https://orcid.org/0000-0003-2206-8308
Sheng JinDepartment of Physiology, Hebei Medical University, Hebei 050017, China.ORCID https://orcid.org/0000-0001-7777-9700
Yuming WuDepartment of Physiology, Hebei Medical University, Hebei 050017, China.ORCID https://orcid.org/0000-0002-3282-056X
Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is posing a great threat to the global economy and public health security. Together with the acknowledged angiotensin-converting enzyme 2, glucose-regulated protein 78, transferrin receptor, AXL, kidney injury molecule-1, and neuropilin 1 are also identified as potential receptors to mediate SARS-CoV-2 infection. Therefore, how to inhibit or delay the binding of SARS-CoV-2 with the abovementioned receptors is a key step for the prevention and treatment of COVID-19. As the third gasotransmitter, hydrogen sulfide (H

Indexed as

AnimalsAntiviral AgentsHumansHydrogen SulfideOrgan SpecificityProtective AgentsReceptors, Cell SurfaceSARS-CoV-2Antiviral AgentsHydrogen SulfideProtective AgentsReceptors, Cell Surface

Identifiers

PMID34497683
PMCPMC8421161
OpenAlexW3197328097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.